Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: TPL and Alliacense

Not a single mention of PTSC. And their 3 other products are ones PTSC has zero interest in. Yet Alliacense is 50% funded by PTSC.

About the MMP Portfolio™
The Moore Microprocessor Patent Portfolio contains intellectual property that is jointly owned by the privately-held TPL Group and publicly-held Patriot Scientific Corporation (OTCBB: PTSC). The MMP Portfolio includes seven U.S. patents as well as their European and Japanese counterparts. It is widely recognized that the MMP Portfolio™ protects fundamental technology important to the entire spectrum of microprocessor-based products, including consumer electronics, medical devices, automobiles and aerospace and defense systems. Manufacturers can learn more about how to participate in the MMP Portfolio™ Licensing Program by contacting: mmp-licensing@alliacense.com.

http://www.alliacense.com/Press_Release_Details.aspx?PressID=116

Where is the proof that "Alliacense is 50% funded by PTSC"?

.

.

Be well

Share
New Message
Please login to post a reply